Covalon Technologies Ltd (COV_CDNX) earnings
Quarterly and annual COV_CDNX reports and results, each read against the price at its own news timestamp. Back to the COV_CDNX overview →
5 measured COV_CDNX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Covalon Reports Fiscal 2026 Third Quarter Results | Press release | — | — | |
| Covalon Reports 2026 Second Quarter Results | Press release | — | — | |
| Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights | Press release | — | — | |
| Covalon Reports Fifth Consecutive Quarter of Positive Earnings | Press release | — | — | |
| Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings | Press release | — | — |
Keep exploring
More COV_CDNX: analyst actions → · SEC filings → · COV_CDNX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SIRONA BIOCHEM CORP ORD (SRBCF) | 66 | 0.00% | 22% |
| VASO CORPORATION (VASO) | 66 | +0.71% | 57% |
| EMERGENT HEALTH CORP (EMGE) | 65 | 0.00% | 33% |
| EASTGATE BIOTECH CORP (ETBI) | 65 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.